Skip to content
SafetyScorer

Is FreeStyle LibreLink safe?

FreeStyle LibreLink

FreeStyle LibreLink is a careful app for reading Abbott glucose sensors: no tracking on the store labels and US data under HIPAA. The watch points are research data kept after deletion, two-step login only in some countries, and a 2025 Libre 3 sensor recall linked to seven deaths.

Medium confidence#11 of 62 in Health, family and learning
Updated
Spot a mistake?

#11of 62 in Health, family and learning

Medium confidence
Agree with our score?
Maker
Abbott Diabetes Care (Alameda, California), part of Abbott
Works with
FreeStyle Libre sensors; in the US, the 10-day and 14-day sensors (newer sensors use Abbott's Libre app)
App Store label
No "Data Used to Track You" section; health, contact and identifiers linked to you for app functionality
Cloud service
LibreView, hosted on AWS, Microsoft Azure or CROC, with servers in the US, EU, Russia, UAE and Asia-Pacific
US health privacy law
Abbott Diabetes Care says US data may be protected by HIPAA under its Notice of Privacy Practices
Sensor recall
Class I, Libre 3 and 3 Plus sensors, November 2025; 7 deaths and 860 serious injuries reported by January 2026
Vulnerability reports
Coordinated disclosure through [email protected]; no cash rewards
App Store rating
4+

How the score breaks down

The overall score is the weighted average of these factors. Scoring rules

  • Privacy30% of score

    68 out of 100, Fair

    Apple's label shows health, contact and identifier data linked to you for app functionality, and location, usage and diagnostics not linked to you; there is no tracking section. Google Play says no data is shared. The September 2026 policy allows opt-in research and marketing use of sensor data outside the US.

  • Security30% of score

    66 out of 100, Fair

    Abbott's policy describes cryptographic protection and periodic independent audits, but says two-step login is required only in certain countries. We found no reported LibreView breach. Abbott takes vulnerability reports through HackerOne without rewards. NVD lists CVE-2020-8997, an NFC flaw in older Libre sensors fixed in 2018.

  • Transparency and control15% of score

    72 out of 100, Good

    You can delete your LibreView account yourself on libreview.com, and Abbott says it erases the data six months later. Research and marketing use outside the US is opt-in. Data already de-identified for research is kept after deletion, and Abbott cannot correct uploaded sensor readings.

  • Scams and harmful content15% of score

    76 out of 100, Good

    The app has no contact with strangers; readings are shared only with clinics and the LibreLinkUp followers you invite. The real risk is a wrong reading. FDA classed the November 2025 Libre 3 sensor correction as Class I after false low readings, though Abbott said apps were not affected.

  • Regulatory record10% of score

    85 out of 100, Excellent

    We found no privacy or consumer-protection fine naming LibreLink. FDA reviews the app as part of a medical device system, and the sensor and reader recalls of 2023 to 2025 were device corrections by Abbott, not fines or orders, so they count as context only.

Yes, for privacy and security it is one of the better health apps we have scored. FreeStyle LibreLink turns your phone into the reader for Abbott's FreeStyle Libre glucose sensors and sends readings to Abbott's LibreView cloud, where your clinic can see them. Neither app store shows tracking or sharing with ad firms, and in the US Abbott handles the data under HIPAA. We score it 71/100, just behind MyChart (74) and ahead of healow (69).

The bigger safety question for most users is not data but accuracy. In November 2025 Abbott corrected millions of Libre 3 sensors that could show falsely low glucose, and FDA classed it as a Class I recall, its most serious type.

Which app do you need?

In the US, FreeStyle LibreLink now works with the older 10-day and 14-day sensors. Abbott's newer Libre app, launched in 2025, covers every Libre sensor except the original 14-day one, and has many more ratings on the App Store. LibreLink still gets updates (version 2.13.1 in April 2026). Abbott's privacy notice covers LibreLink, the Libre apps, the LibreLinkUp follower app and LibreView together, so most of this page applies to all of them.

What Abbott collects and where it goes

Apple's label for LibreLink lists health, contact, user content and identifier data linked to you, all for app functionality. Location, identifiers, usage and diagnostics are collected for analytics but not linked to you. There is no "Data Used to Track You" section. On Google Play, Abbott says it shares no data with other companies.

The September 2026 privacy notice adds detail. LibreView runs on Amazon Web Services, Microsoft Azure or CROC, with servers in North America, Europe, Russia, the UAE and Asia-Pacific depending on where you live. Outside the US, Abbott uses de-identified data for research only if you opt in, and with your opt-in can use your profile, sensor start time, frequency of use and glucose information for marketing. De-identified research data stays with Abbott after you delete your account, and can go to outside researchers and health authorities.

For US users, the notice says data shared through Libre products "may be protected" by HIPAA, under the Abbott Diabetes Care Notice of Privacy Practices. That is stronger cover than most consumer health apps get; compare Flo, which falls outside HIPAA.

How secure is LibreView?

Abbott says it uses "cryptographic technologies," limits staff access and has its compliance checked through periodic independent audits. Two-step login, though, is required only "in certain countries," so in many places a password is all that protects years of glucose history. We found no reported breach of LibreView.

Abbott runs a coordinated disclosure programme for its devices and lists it on HackerOne, with reports going to [email protected] and no cash rewards. The best-known security flaw, CVE-2020-8997, let someone close by unlock write access to the memory of older Libre sensors over NFC. NVD notes it was not present in the US 14-day sensor from August 2018 or Libre 2 from October 2018.

The sensor recalls

FDA lists several Libre recalls since 2023. Reader batteries that could swell or overheat led to a Class I recall in February 2023. A Libre 3 app fault on Android 13 that caused long signal loss was a Class II recall the same month. In July 2024 some Libre 3 sensors gave falsely high readings (Class I).

The largest came on 24 November 2025, when Abbott sent an urgent correction for certain Libre 3 and Libre 3 Plus sensors with a manufacturing fault that could cause falsely low readings. FDA's enforcement data lists about 3 million affected sensors. By 7 January 2026 Abbott had reported seven deaths and 860 serious injuries linked to the fault, FDA says. A falsely low reading can lead someone to eat extra carbohydrates or skip insulin. Abbott said readers and apps were not affected, and LibreLink in the US reads older sensors. These are device corrections, not privacy fines, so they do not lower the regulatory score, but they matter more to your health than any setting in the app.

  1. Check any Libre 3 or Libre 3 Plus sensor serial number at freestylecheck.com.
  2. Confirm a reading with a fingerstick when symptoms do not match the number, as the app's own instructions require a backup meter.
  3. Use a strong, unique LibreView password, and turn on two-step login if your country offers it.
  4. Review your LibreLinkUp followers and connected clinics, and remove the ones you no longer need.
  5. Leave research and marketing opt-ins off unless you want them.

How we scored it

Regulatory record (85) is the strongest factor, with no privacy fine against Abbott's Libre apps. Scams and harmful content (76) loses points because wrong sensor readings, not strangers, are the real harm. Transparency and control (72) credits self-service account deletion. Privacy (68) and security (66) reflect no tracking and audited systems, held back by research data kept after deletion and two-step login that is not required everywhere.

Questions people ask

Does Abbott sell my FreeStyle Libre data?

The privacy notice does not describe selling your identifiable data for money. Outside the US, Abbott uses de-identified data for research only if you opt in, and uses your profile and sensor-use data for marketing only if you opt in. Abbott may transfer your personal data to a buyer if it sells the product line.

Is LibreView covered by HIPAA?

For US users, Abbott says data you or your clinic share through Libre products may be protected by HIPAA, and it handles it under the Abbott Diabetes Care Notice of Privacy Practices on LibreView. Data you share with Abbott outside that covered entity, for example by consenting to other uses, falls under Abbott's general privacy policy and state privacy laws.

Was my sensor part of the FreeStyle Libre 3 recall?

The November 2025 recall covered certain FreeStyle Libre 3 and Libre 3 Plus sensors that could give falsely low readings. Abbott set up freestylecheck.com to check serial numbers and told users to stop using and throw away affected sensors. The recall did not cover the older sensors that FreeStyle LibreLink reads in the US.

Who can see my glucose readings in LibreLink?

Abbott, your clinic if you connect to its LibreView practice, and anyone you invite to follow you in the LibreLinkUp app. Followers can see your readings and alarms in near real time. Review the list in the app's settings and remove anyone who no longer needs it.

How do I delete my FreeStyle LibreLink data?

Log in at libreview.com and use the delete account option. Abbott says it erases personal data six months after deletion, except data already de-identified for research or data it must keep by law. Deleting the app from your phone does not delete your LibreView account.

Sources

  1. 1.FreeStyle LibreLink - US, App Store listing and App Privacy label (opens in a new tab) · Apple App Store, 2026
  2. 2.FreeStyle LibreLink - US data safety section (opens in a new tab) · Google Play, 2026
  3. 3.Libre Family of Products Global Privacy Notice (effective September 2026) (opens in a new tab) · Abbott Diabetes Care, 2026
  4. 4.Medical Device Recall Z-1020-2026, FreeStyle Libre 3 Sensor (Class 1) (opens in a new tab) · US Food and Drug Administration, 2026
  5. 5.openFDA device enforcement reports, Abbott FreeStyle Libre recalls (opens in a new tab) · US Food and Drug Administration, 2026
  6. 6.Glucose Monitor Sensor Recall: Abbott Diabetes Care Removes Certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus Sensors (opens in a new tab) · US Food and Drug Administration, 2026
  7. 7.Abbott cybersecurity and coordinated disclosure (opens in a new tab) · Abbott, 2026
  8. 8.CVE-2020-8997 (opens in a new tab) · NIST National Vulnerability Database, 2020
Spot a mistake?